CClinicalTrials.gg
CompletedNCT05486442Updated Aug 3, 2022

ACT for Weight-related Experiential Avoidance

An interventional study of ACT for weight-related experiential avoidance in Eating Behavior, sponsored by Bahcesehir Cyprus University. Completed at 1 site in Cyprus. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-08-03.

Sponsored by Bahcesehir Cyprus University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Mar 2022, registered Jul 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aimed to investigate whether Acceptance and Commitment Therapy/Training would be helpful to reduce weight-related experiential avoidance among individuals who reported weight concern

Read the detailed description

This quasi-experimental study aimed to examine the efficacy of Acceptance and Commitment Therapy/Training (ACT) in reducing weight-related experiential avoidance. Data were collected with a convenience sampling technique. After obtaining ethical approval, participants were invited to participate in the study via advertisements, and online posts. Due to the small sample size, participants who were willing to attend group discussions were included in the experimental group. Participants in the control group did not receive manipulation. All participants were provided with an informed consent form. All participants completed a questionnaire measuring outcomes (weight-related experiential avoidance, general experiential avoidance, eating attitudes, and social physique anxiety) at pre-test, post-test, and follow-up. Participants in the experimental group received ACT training including 6 sessions. The protocol was adapted from Pearson et al. (2012) with their permission. Each session took approximately 80 mins. Several aspects of ACT approach were discussed in the sessions. In session one, ACT approach was introduced. In session two, creative hopelessness was discussed. In session three, control strategies related to weight concern were identified. In session four, mindfulness exercises were completed. In the fifth session, values for meaningful life experience were discussed. In the last, sixth session, the ways to commit to action were discussed. Each session included exercises and homework. At the end of the study, the participants were provided with debrief form.

02

Conditions studied

  • Eating Behavior
03

In context

Lead sponsor

Bahcesehir Cyprus University is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Individuals who were 18 years and older
  • Ability to read and understand Turkish

Exclusion criteria

Exclusion Criteria:

  • Individuals who have received mental health intervention over the last one year
  • and those who were diagnosed with an eating disorder were excluded from the analyses
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
32 participants (actual)

Study arms

  • Experimental
    Experimental group

    Participants in the experimental group received ACT training in the group setting aiming to reduce weight-related experiential avoidance. This included 6 sessions in total. Each session was completed approximately in 80 mins.

    Behavioral: ACT for weight-related experiential avoidance

  • No intervention
    Control group

    Participants in the control group did not receive any manipulation

Interventions

  • BehavioralACT for weight-related experiential avoidance

    Participants in the experimental group received weight concern-related ACT training in a group setting. Each session focused on different dimensions of ACT and included relevant exercises and homeworks. Dimensions studied included creative hopelessness, control strategies, mindfulness exercises, values and barries to values and commitment to action.

06

What researchers measure

Primary outcomes

  1. Change in weight-related experiential avoidance

    It was measured by Acceptance and Action Questionnaire for Weight-Related Difficulties-Revised. The scale includes 10 items that are rated on 7 points scale (1 = not true at all - 7 = completely true). Higher scores indicate greater weight related experiential avoidance.

    Time frame: At three time points (pre-intervention [baseline], immediately after the intervention, and at three weeks after the intervention)

Secondary outcomes

  1. Change in eating attitudes

    Eating attitudes were measured by The Eating Attitudes Test-26. It includes 26 items that are rated on 4 point scale ('3 = Always, 2 = Usually, 1 = Often, 0 = Sometimes, Rarely, and Never'). The last item (26) requires reverse coding. Scores 20 and above indicate dysfunctional eating attitudes.

    Time frame: At three time points (pre-intervention [baseline], immediately after the intervention, and at three weeks after the intervention)

  2. Change in general experiential avoidance

    It was measured by Acceptance and Action Questionnaire-II. It includes 7 items that are rated on 7 point scale (1 = never true - 7 = always true). Minimum and maximum scores range between 7 and 49 points. Higher scores indicate greater general experiential avoidance (psychological inflexibility).

    Time frame: At three time points (pre-intervention [baseline], immediately after the intervention, and at three weeks after the intervention)

  3. Change in social physique anxiety

    It was measured by The Social Physique Anxiety Scale. The scale includes 12 items are rated on a 5-point scale (1=not at all true to 5=extremely true). Higher scores indicate a higher level of anxiety related to the social physique. Only item 1, 2, 5, 8 and 11 requires reverse coding.

    Time frame: At three time points (pre-intervention [baseline], immediately after the intervention, and at three weeks after the intervention)

07

Study locations

1 site
  • Near East University
    Nicosia, Cyprus
08

References and documents

Publications

  • Pearson, Adria N., Victoria M. Follette, and Steven C. Hayes.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 3, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05486442
Lead sponsor
Bahcesehir Cyprus University
Responsible party
Buse Keskindag (Principal Investigator, Bahcesehir Cyprus University) — Principal investigator
First posted
Aug 3, 2022
Start date
Mar 4, 2022
Primary completion
Jun 3, 2022
Completion
Jun 3, 2022
Last update
Aug 3, 2022

Study contacts

Meryem Karaaziz, PhD
study director · Near East University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion